Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Anderson

Showing results (351-360 of 378) with videos related to

Pageof 38
Sort By:
European Radiology|January 6, 2026
A multicenter multinational retrospective study of the 1-year natural history of LI-RADS 3 observations in patients with cirrhosisLuigi Asmundo, Nathaniel Mercaldo, Felipe Furtado, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2John P Miller, Kyu Kwang Kim, Cameron Wa Snyder, et al.
BMC Infectious Diseases|February 22, 2022
Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021Charles Ssuuna, Ronald Moses Galiwango, Edward Nelson Kankaka, et al.
Research Square|October 27, 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Seropositivity in South-Central Uganda, During 2019 - 2021Charles Ssuuna, Ronald Moses Galiwango, Edward Nelson Kankaka, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 <sup>+</sup> T cell responsesJillian M Jespersen J, Lia Avanesyan, Jean Publicover, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERGZoran Rankovic, Jiaqiang Cai, Jennifer Kerr, et al.
Public Health Reports (Washington, D.C. : 1974)|June 6, 2022
Partnership Between a Federal Agency and 4 Tribal Nations to Improve COVID-19 Response CapacitiesHarpriya Kaur, Seh Welch, Ravikiran Bhairavabhotla, et al.
Science Translational Medicine|April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responsesJillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
Intensive Care Medicine|February 2, 2021
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19Shahzad Shaefi, Samantha K Brenner, Shruti Gupta, et al.
Pageof 38

Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
European Radiology|January 6, 2026
A multicenter multinational retrospective study of the 1-year natural history of LI-RADS 3 observations in patients with cirrhosisLuigi Asmundo, Nathaniel Mercaldo, Felipe Furtado, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2John P Miller, Kyu Kwang Kim, Cameron Wa Snyder, et al.
BMC Infectious Diseases|February 22, 2022
Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021Charles Ssuuna, Ronald Moses Galiwango, Edward Nelson Kankaka, et al.
Research Square|October 27, 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Seropositivity in South-Central Uganda, During 2019 - 2021Charles Ssuuna, Ronald Moses Galiwango, Edward Nelson Kankaka, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 <sup>+</sup> T cell responsesJillian M Jespersen J, Lia Avanesyan, Jean Publicover, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERGZoran Rankovic, Jiaqiang Cai, Jennifer Kerr, et al.
Public Health Reports (Washington, D.C. : 1974)|June 6, 2022
Partnership Between a Federal Agency and 4 Tribal Nations to Improve COVID-19 Response CapacitiesHarpriya Kaur, Seh Welch, Ravikiran Bhairavabhotla, et al.
Science Translational Medicine|April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responsesJillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
Intensive Care Medicine|February 2, 2021
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19Shahzad Shaefi, Samantha K Brenner, Shruti Gupta, et al.
Pageof 38